---
title: "600993.SH (600993.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600993.SH/news.md"
symbol: "600993.SH"
name: "600993.SH"
parent: "https://longbridge.com/en/quote/600993.SH.md"
datetime: "2026-05-20T19:30:38.621Z"
locales:
  - [en](https://longbridge.com/en/quote/600993.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600993.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600993.SH/news.md)
---

# 600993.SH (600993.SH) — Related News

### [The acquirer abandoned the purchase midway, and MYL's transfer of hospital assets worth 104 million failed](https://longbridge.com/en/news/286246133.md)
*2026-05-13T10:45:15.000Z*
> MYL Medical Management Co., Ltd. originally planned to transfer 79.8144% of its controlling subsidiary Beijing MYL Chang

### [Selling anorectal hospitals to "slim down" but facing a breach of contract, MYL's net profit expectation of nearly 70 million falls short](https://longbridge.com/en/news/285815252.md)
*2026-05-09T14:01:55.000Z*
> MYL failed to successfully sell 79.8144% of its controlling subsidiary MYL Medical Management, resulting in an expected 

### [MYL: The holding subsidiary terminates the transfer of equity in its subordinate company](https://longbridge.com/en/news/285682951.md)
*2026-05-08T07:34:45.000Z*
> MYL announced that the equity transfer contract signed between its controlling subsidiary MYL Medical Management Co., Lt

### [The billion-dollar "Hemorrhoid Master" sees growth slow down; can ophthalmic and skin products provide a solution?](https://longbridge.com/en/news/284392862.md)
*2026-04-28T12:56:20.000Z*
> MYL achieved revenue of 3.867 billion yuan in 2025, a year-on-year increase of 3.72%; net profit attributable to the par

### [MYL's performance in 2025 shows resilience with counter-cyclical growth, and the health business has become the second growth curve](https://longbridge.com/en/news/284162136.md)
*2026-04-27T06:09:08.000Z*
> MYL achieved operating revenue of 3.867 billion yuan in 2025, a year-on-year increase of 3.72%; net profit attributable 

### [Low revenue growth and new business awaiting evaluation. After selling 200 million tubes of hemorrhoid cream, what will MYL rely on to take over?](https://longbridge.com/en/news/284085125.md)
*2026-04-25T14:09:10.000Z*
> MYL's 2025 annual report shows that the total revenue for the year was 3.867 billion yuan, a year-on-year increase of 3.

### [MYL: Net profit in the first quarter was 213 million yuan, a year-on-year increase of 4.43%](https://longbridge.com/en/news/283982082.md)
*2026-04-24T10:34:24.000Z*
> MYL announced that the operating revenue in the first quarter of 2026 was 1.012 billion yuan, a year-on-year increase of

### [MYL: Net profit of 581 million yuan in 2025, a year-on-year increase of 10.11%](https://longbridge.com/en/news/283982068.md)
*2026-04-24T10:34:21.000Z*
> MYL announced that the operating revenue in 2025 is expected to be 3.867 billion yuan, a year-on-year increase of 3.72%.

### [CBG plans to transfer its 79.8144% equity stake in Beijing MYL Changqing Hospital Management Co., Ltd. to Zhuozhun Technology](https://longbridge.com/en/news/281006083.md)
*2026-03-30T11:07:22.000Z*
> CBG announced that its holding subsidiary MYL Medical Management Co., Ltd. has signed a share transfer contract with Zhu